Literature DB >> 22318353

Secondary acute myeloid leukemia occurring after successful treatment of acute promyelocytic leukemia.

Junfa Chen, Zhiyin Zheng, Jianping Shen, Leijun Peng, Haifeng Zhuang, Wenbin Liu, Yuhong Zhou.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22318353     DOI： 10.1007/s12185-012-1019-8

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  11 in total

1.  Clinical and biological features of acute myeloid leukaemia occurring as second malignancy: GIMEMA archive of adult acute leukaemia.

Authors:  L Pagana; A Pulsoni; M E Tosti; G Avvisati; L Mele; M Mele; B Martino; G Visani; R Cerri; E Di Bona; R Invernizzi; A Nosari; M Clavio; B Allione; P Coser; A Candoni; A Levis; A Camera; L Melillo; G Leone; F Mandelli
Journal:  Br J Haematol       Date:  2001-01       Impact factor: 6.998

2.  Cancer survivors: living longer, and now, better.

Authors: 
Journal:  Lancet       Date:  2004 Dec 18-31       Impact factor: 79.321

Review 3.  Treatment of acute lymphoblastic leukemia.

Authors:  Ching-Hon Pui; William E Evans
Journal:  N Engl J Med       Date:  2006-01-12       Impact factor: 91.245

4.  Acute myeloid leukemia in patients previously diagnosed with breast cancer: experience of the GIMEMA group.

Authors:  L Pagano; A Pulsoni; L Mele; M E Tosti; R Cerri; G Visani; L Melillo; A Candoni; M Clavio; A Nosari; M C Petti; B Martino; A Mele; A Levis; B Allione; C Almici; F Equitani; G Leone; F Mandelli
Journal:  Ann Oncol       Date:  2001-02       Impact factor: 32.976

Review 5.  The incidence of secondary leukemias.

Authors:  G Leone; L Mele; A Pulsoni; F Equitani; L Pagano
Journal:  Haematologica       Date:  1999-10       Impact factor: 9.941

6.  Leukemia following Hodgkin's disease.

Authors:  J M Kaldor; N E Day; E A Clarke; F E Van Leeuwen; M Henry-Amar; M V Fiorentino; J Bell; D Pedersen; P Band; D Assouline
Journal:  N Engl J Med       Date:  1990-01-04       Impact factor: 91.245

7.  Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience.

Authors:  Lionel Adès; Agnes Guerci; Emmanuel Raffoux; Miguel Sanz; Patrice Chevallier; Simona Lapusan; Christian Recher; Xavier Thomas; Consuelo Rayon; Sylvie Castaigne; Olivier Tournilhac; Stephane de Botton; Norbert Ifrah; Jean-Yves Cahn; Eric Solary; Claude Gardin; Nathalie Fegeux; Dominique Bordessoule; Augustin Ferrant; Sandrine Meyer-Monard; Norbert Vey; Herve Dombret; Laurent Degos; Sylvie Chevret; Pierre Fenaux
Journal:  Blood       Date:  2009-12-17       Impact factor: 22.113

8.  Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.

Authors:  C H Pui; R C Ribeiro; M L Hancock; G K Rivera; W E Evans; S C Raimondi; D R Head; F G Behm; M H Mahmoud; J T Sandlund
Journal:  N Engl J Med       Date:  1991-12-12       Impact factor: 91.245

9.  Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia.

Authors:  Jiong Hu; Yuan-Fang Liu; Chuan-Feng Wu; Fang Xu; Zhi-Xiang Shen; Yong-Mei Zhu; Jun-Min Li; Wei Tang; Wei-Li Zhao; Wen Wu; Hui-Ping Sun; Qiu-Sheng Chen; Bing Chen; Guang-Biao Zhou; Arthur Zelent; Samuel Waxman; Zhen-Yi Wang; Sai-Juan Chen; Zhu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-18       Impact factor: 11.205

10.  Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study.

Authors:  J P Neglia; D L Friedman; Y Yasui; A C Mertens; S Hammond; M Stovall; S S Donaldson; A T Meadows; L L Robison
Journal:  J Natl Cancer Inst       Date:  2001-04-18       Impact factor: 11.816
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.